Literature DB >> 7114932

The role of surgery in patients with Zollinger-Ellison syndrome (ZES) managed medically.

M F Brennan, R T Jensen, R A Wesley, J L Doppman, D M McCarthy.   

Abstract

From 1975 to 1981, the authors' deliberate intent was to treat all patients with Zollinger-Ellison syndrome (ZES) medically. This allowed the authors to ask the question of the need for surgical intervention in patients managed medically. Twenty-six patients followed for an average of 37 months (range 2 to 147 months) from diagnosis were maintained on cimetidine for a mean of 32 months (2 to 64 months). Six of these patients (23%) were unable to be maintained on cimetidine and required surgery during this period. Four received total gastrectomy, and two had lesser operations. Analysis of survival curves in this small group does not illustrate a difference between outcome based on surgical or medical management. Prospective studies based on aggressive attempts at preoperative localization with staging laparotomy and tumor resection seem justified.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114932      PMCID: PMC1352590          DOI: 10.1097/00000658-198209000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

Authors:  E H ELLISON; S D WILSON
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

2.  Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.

Authors:  R M ZOLLINGER; E H ELLISON
Journal:  Ann Surg       Date:  1955-10       Impact factor: 12.969

3.  Pancreatic vein catheterization with gastrin assay in normal patients and in patients with the Zollinger-Ellison syndrome.

Authors:  S Ingemansson; L I Larsson; A Lunderquist; F Stadil
Journal:  Am J Surg       Date:  1977-11       Impact factor: 2.565

4.  Hyperparathyroidism--a reversible cause of cimetidine-resistant gastric hypersecretion.

Authors:  D M McCarthy; S R Peikin; R N Lopatin; B W Long; A Spiegel; S Marx; M Brennan
Journal:  Br Med J       Date:  1979-06-30

Review 5.  Surgical management of the Zollinger-Ellison syndrome.

Authors:  P S Fox; J W Hofmann; S D Wilson; J J DeCosse
Journal:  Surg Clin North Am       Date:  1974-04       Impact factor: 2.741

6.  Primary peptic ulcerations of the jejunum associated with islet cell tumors. Twenty-five-year appraisal.

Authors:  R M Zollinger; E C Ellison; P J Fabri; J Johnson; J Sparks; L C Carey
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

7.  Report on the United States experience with cimetidine in Zollinger-Ellision syndrome and other hypersecretory states.

Authors:  D M McCarthy
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors.

Authors:  P S Fox; J W Hofmann; J J Decosse; S D Wilson
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

9.  Computed tomographic detection of nonbeta pancreatic islet cell tumors.

Authors:  N R Dunnick; J L Doppman; S R Mills; D M McCarthy
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

10.  Effect of vagotomy in Zollinger-Ellison syndrome.

Authors:  C T Richardson; M Feldman; R N McClelland; R M Dickerman; D Kumpuris; J S Fordtran
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  13 in total

Review 1.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

2.  Malignant islet-cell tumors of the pancreas.

Authors:  N W Thompson; F E Eckhauser
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

3.  Current approach to the management of tumoral process in patients with gastrinoma.

Authors:  M Mignon; P Ruszniewski; S Haffar; D Rigaud; E Rene; S Bonfils
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

4.  MEN I pancreas: a histological and immunohistochemical study.

Authors:  N W Thompson; R V Lloyd; R H Nishiyama; A I Vinik; W E Strodel; M D Allo; F E Eckhauser; G Talpos; T Mervak
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

5.  Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; J L Doppman; M J Collen; J W Harmon; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

6.  Removal of gastrinomas for control of Zollinger-Ellison syndrome.

Authors:  J W Harmon; J A Norton; M J Collin; A G Krudy; T H Shawker; J L Doppman; J d'Avis; R T Jensen
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

7.  The role of surgery in the Zollinger-Ellison syndrome.

Authors:  J C Thompson; B G Lewis; I Wiener; C M Townsend
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

8.  Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome.

Authors:  N W Thompson; A I Vinik; F E Eckhauser
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

9.  Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.

Authors:  J A Norton; P H Sugarbaker; J L Doppman; R A Wesley; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

Review 10.  Current diagnosis and management of Zollinger-Ellison syndrome.

Authors:  D K Andersen
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.